162 related articles for article (PubMed ID: 35448493)
1. Serum Lipidome Signatures of Dogs with Different Endocrinopathies Associated with Hyperlipidemia.
Sieber-Ruckstuhl NS; Tham WK; Baumgartner F; Selva JJ; Wenk MR; Burla B; Boretti FS
Metabolites; 2022 Mar; 12(4):. PubMed ID: 35448493
[TBL] [Abstract][Full Text] [Related]
2. UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia.
Shenghua P; Shuyu T; Kunping L; Huixia Z; Xue X; Jiao G
Evid Based Complement Alternat Med; 2018; 2018():4530849. PubMed ID: 30245731
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipidomics in subjects with combat posttraumatic stress disorder.
Konjevod M; Sáiz J; Nikolac Perkovic M; Nedic Erjavec G; Tudor L; Uzun S; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Strac DS
Free Radic Biol Med; 2022 Aug; 189():169-177. PubMed ID: 35918015
[TBL] [Abstract][Full Text] [Related]
4. Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.
Aicher KM; Cullen JM; Seiler GS; Lunn KF; Mathews KG; Gookin JL
PLoS One; 2019; 14(2):e0212638. PubMed ID: 30811473
[TBL] [Abstract][Full Text] [Related]
5. Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits.
Bojic LA; McLaren DG; Shah V; Previs SF; Johns DG; Castro-Perez JM
Int J Mol Sci; 2014 Dec; 15(12):23283-93. PubMed ID: 25517033
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure.
Sieber-Ruckstuhl NS; Burla B; Spoerel S; Schmid F; Venzin C; Cazenave-Gassiot A; Bendt AK; Torta F; Wenk MR; Boretti FS
Sci Rep; 2019 Apr; 9(1):6015. PubMed ID: 30979907
[TBL] [Abstract][Full Text] [Related]
7. Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes.
Kostara CE; Ferrannini E; Bairaktari ET; Papathanasiou A; Elisaf M; Tsimihodimos V
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266469
[TBL] [Abstract][Full Text] [Related]
8. Primary thyroid disorders in endogenous Cushing's syndrome.
Niepomniszcze H; Pitoia F; Katz SB; Chervin R; Bruno OD
Eur J Endocrinol; 2002 Sep; 147(3):305-11. PubMed ID: 12213667
[TBL] [Abstract][Full Text] [Related]
9. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
Zhang L; Hu Y; An Y; Wang Q; Liu J; Wang G
Front Endocrinol (Lausanne); 2022; 13():677202. PubMed ID: 35432194
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics as a principal tool for advancing biomedical research.
Lam SM; Shui G
J Genet Genomics; 2013 Aug; 40(8):375-90. PubMed ID: 23969247
[TBL] [Abstract][Full Text] [Related]
11. Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice.
Boué S; Tarasov K; Jänis M; Lebrun S; Hurme R; Schlage W; Lietz M; Vuillaume G; Ekroos K; Steffen Y; Peitsch MC; Laaksonen R; Hoeng J
Atherosclerosis; 2012 Dec; 225(2):328-34. PubMed ID: 23102783
[TBL] [Abstract][Full Text] [Related]
12. Untargeted UHPLC-ESI-QTOF-MS/MS analysis with targeted feature extraction at precursor and fragment level for profiling of the platelet lipidome with ex vivo thrombin-activation.
Cebo M; Calderón Castro C; Schlotterbeck J; Gawaz M; Chatterjee M; Lämmerhofer M
J Pharm Biomed Anal; 2021 Oct; 205():114301. PubMed ID: 34391135
[TBL] [Abstract][Full Text] [Related]
13. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients.
Castañé H; Iftimie S; Baiges-Gaya G; Rodríguez-Tomàs E; Jiménez-Franco A; López-Azcona AF; Garrido P; Castro A; Camps J; Joven J
Metabolism; 2022 Jun; 131():155197. PubMed ID: 35381232
[TBL] [Abstract][Full Text] [Related]
14. Pattern of Lipid Abnormalities Among South Asian Indians With Cushing's Syndrome and the Short Term Impact of Surgical Correction of Hypercortisolism.
Dhingra A; Ganie MA; Dharmshaktu P; Chakraborty S; Jyotsna VP; Gupta N
Horm Metab Res; 2019 May; 51(5):309-314. PubMed ID: 31071735
[TBL] [Abstract][Full Text] [Related]
15. Integrated Lipidomics and Transcriptomics Characterization upon Aging-Related Changes of Lipid Species and Pathways in Human Bone Marrow Mesenchymal Stem Cells.
Lu X; Chen Y; Wang H; Bai Y; Zhao J; Zhang X; Liang L; Chen Y; Ye C; Li Y; Zhang Y; Li Y; Ma T
J Proteome Res; 2019 May; 18(5):2065-2077. PubMed ID: 30827117
[TBL] [Abstract][Full Text] [Related]
16. Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics.
Lee H; Choi JM; Cho JY; Kim TE; Lee HJ; Jung BH
Chem Phys Lipids; 2018 Aug; 214():69-83. PubMed ID: 29852124
[TBL] [Abstract][Full Text] [Related]
17. Serum lipidome analysis of healthy beagle dogs receiving different diets.
Boretti FS; Burla B; Deuel J; Gao L; Wenk MR; Liesegang A; Sieber-Ruckstuhl NS
Metabolomics; 2019 Dec; 16(1):1. PubMed ID: 31797205
[TBL] [Abstract][Full Text] [Related]
18. Lipid Abnormalities in Patients With Cushing's Disease and Its Relationship With Impaired Glucose Metabolism.
Sun X; Feng M; Lu L; Zhao Z; Bao X; Deng K; Yao Y; Zhu H; Wang R
Front Endocrinol (Lausanne); 2020; 11():600323. PubMed ID: 33633684
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.
Kotłowska A; Puzyn T; Sworczak K; Stepnowski P; Szefer P
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146078
[TBL] [Abstract][Full Text] [Related]
20. Lipidomic architecture shared by subclinical markers of osteoporosis and atherosclerosis: The Cardiovascular Risk in Young Finns Study.
Mishra BH; Mishra PP; Mononen N; Hilvo M; Sievänen H; Juonala M; Laaksonen M; Hutri-Kähönen N; Viikari J; Kähönen M; Raitakari OT; Laaksonen R; Lehtimäki T
Bone; 2020 Feb; 131():115160. PubMed ID: 31759205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
